However, here are some of the changes and goals people taking semaglutide should be aiming for during their treatment journey Moderate your carbohydrates this can be as simple as swapping out things like chips and pretzels for nuts or almonds
The overall trajectory remains positive, but the path is less linear
That isnt marketing
Blue Cross Blue Shield of Michigan and Blue Care Network GLP-1 Update On June 6, 2024, Blue Cross Blue Shield of Michigan and Blue Care Network announced they plan to change the criteria for coverage of GLP-1 obesity drugs, including Wegovy, Saxenda and Zepbound effective August 1, 2024
Lilly will continue to pursue legal remedies against those who falsely claim their products are Mounjaro, Zepbound, or FDA-approved tirzepatide, including certain med-spas, wellness centers, online retailers, and compounding pharmacies. Simply put, the Big Pharma lobby is strong, the lawyers are ready and waiting, and were talking about the most commercialize-able drug in history